|
|
||||||||

Unité Bio-Agresseurs, Santé, Environnement, Institut National de la Recherche Agronomique, Centre de Recherche de Tours, 37380 Nouzilly, France
Correspondence Elisabeth Chaslus-Dancla chaslus{at}tours.inra.fr
Received January 14, 2003
Accepted April 16, 2003
High-level fluoroquinolone (FQ) resistance is still infrequent in salmonellae, compared with other pathogenic enterobacteria. Data provided in this work support the hypothesis that the mechanisms that confer high-level FQ resistance on salmonellae have a prohibitive fitness cost and may thus limit the emergence of highly resistant clones. In vitro mutants that were highly resistant to ciprofloxacin (MIC = 8 and 16 µg ml-1) showed generation times 1.4- and 2-fold longer than their parent strains and were unable to colonize the gut of chickens. Electron microscopy showed an altered morphology for one of these mutants grown to stationary phase. Mutants selected in vivo and exhibiting intermediate resistance to ciprofloxacin (MIC = 2 µg ml-1) also showed growth defects on solid media but had normal generation times in liquid culture and colonized the gut of chickens. After in vitro or in vivo passage in the absence of antibiotic selective pressure, partial reversals of the fitness cost were observed, which were associated with slight decreases in resistance to quinolones and other unrelated antibiotics, but were not linked to the loss of gyrA mutations.
Present address: UMR INRA/ENVN Chimiothérapie Aquacole et Environnement, Ecole Nationale Vétérinaire de Nantes, Atlanpole La Chantrerie, BP 40706, 44307 Nantes Cedex 03, France. Abbreviation: FQ, fluoroquinolone.
This article has been cited by other articles:
![]() |
M. Akiba, Y. Nakaoka, M. Kida, Y. Ishioka, T. Sameshima, N. Yoshii, M. Nakazawa, I. Uchida, and N. Terakado Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005 J. Antimicrob. Chemother., December 1, 2007; 60(6): 1235 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Rozen, L. McGee, B. R. Levin, and K. P. Klugman Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother., February 1, 2007; 51(2): 412 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Enne, A. A. Delsol, G. R. Davis, S. L. Hayward, J. M. Roe, and P. M. Bennett Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element J. Antimicrob. Chemother., September 1, 2005; 56(3): 544 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Randall, D. J. Eaves, S. W. Cooles, V. Ricci, A. Buckley, M. J. Woodward, and L. J. V. Piddock Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression J. Antimicrob. Chemother., August 1, 2005; 56(2): 297 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Luo, S. Pereira, O. Sahin, J. Lin, S. Huang, L. Michel, and Q. Zhang Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure PNAS, January 18, 2005; 102(3): 541 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kugelberg, S. Lofmark, B. Wretlind, and D. I. Andersson Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa J. Antimicrob. Chemother., January 1, 2005; 55(1): 22 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cabrera, J. Ruiz, F. Marco, I. Oliveira, M. Arroyo, A. Aladuena, M. A. Usera, M. T. Jimenez De Anta, J. Gascon, and J. Vila Mechanism of Resistance to Several Antimicrobial Agents in Salmonella Clinical Isolates Causing Traveler's Diarrhea Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3934 - 3939. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |